- Home
- AIN vs ATAI Comparison
AIN vs ATAI Comparison
Compare AIN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIN | ATAI |
|---|---|---|
| Founded | 1895 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 1987 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIN | ATAI |
|---|---|---|
| Price | $50.62 | $3.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $64.25 | $14.00 |
| AVG Volume (30 Days) | 384.8K | ★ 3.0M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,148,512,000.00 | $3,018,000.00 |
| Revenue This Year | N/A | $943.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 811.78 |
| 52 Week Low | $41.15 | $1.15 |
| 52 Week High | $83.65 | $6.75 |
Technical Indicators
Market Signals| Indicator | AIN | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 41.30 |
| Support Level | $49.70 | $3.88 |
| Resistance Level | $51.50 | $4.33 |
| Average True Range (ATR) | 1.52 | 0.23 |
| MACD | 0.39 | 0.02 |
| Stochastic Oscillator | 55.64 | 15.82 |
Price Performance
Historical ComparisonAbout AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.